Biomarkers aiding diagnosis of atypical presentation of pyridoxine-dependent epilepsy

Pediatric Neurology

Volumn 44, Issue 4, 2011, Pages 289-291

  Segal, Eric B ^a   Grinspan, Zachary M ^b   Mandel, Arthur M ^c   Gospe Jr , Sidney M ^d,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; BIOLOGICAL MARKER; ETIRACETAM; FOLINIC ACID; NEUROTRANSMITTER; PHENOBARBITAL; PHENYTOIN; PIPECOLIC ACID; PYRIDOXINE; TOPIRAMATE;

ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPSY; FAMILY HISTORY; FEMALE; GENETIC SCREENING; HUMAN; INFANT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS;

EID: 79952554626     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.11.012     Document Type: Article

References (15)

1. Hunt AD, Stokes J, McCrory WW, Stroud HH. Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 1954;13:140-5.
2. Gospe SM. Pyridoxine-dependent seizures: New genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 2006;19:148-53.
3. Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 2006;12:307-9. (Pubitemid 43355078)
4. Mills PB, Footitt EJ, Mills KA, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 2010;133:2148-59.
5. Gallagher RC, Van Hove JL, Scharer G, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 2009;65:554-6.
6. Sadilkova K, Gospe SM Jr, Hahn SH. Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures. J Neurosci Methods 2009;184:136-41.
7. Battaglioli G, Rosen DR, Gospe SM, Martin DL. Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures. Neurology 2000;55:309-11. (Pubitemid 30604641)
8. Plecko B, Stöckler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 2000;48:121-5. (Pubitemid 30432442)
9. Goutières F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: A treatable cause of intractable epilepsy in infants. Ann Neurol 1985;17:117-20. (Pubitemid 15170431)
10. Schmitt B, Baumgartner M, Mills PB, et al. Seizures and paroxysmal events: Symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 2010;52:e133-42.
11. Pearl PL. New treatment paradigms in neonatal metabolic epilepsies. J Inherit Metab Dis 2009;32:203-13.
12. Lin J, Lin K, Masruha MR, Vilanova LC. Pyridoxine-dependent epilepsy initially responsive to phenobarbital. Arq Neuropsiquiatr 2007;65:1026-9.
13. Claus SP, Braun KP, Dorland L, Bourrez-Swart M, van Nieuwenhizen O, de Koning TJ. Unexplained epileptic encephalopathy: Consider and reconsider pyridoxine dependent seizures. J Pediatr Neurol 2003;1:51-3.
14. Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: Review of 63 North American cases submitted to a patient registry. Eur J Pediatr 2009;168:697-704.
15. Bendich A, Cohen M. Vitamin B6 safety issues. Ann NYAcad Sci 1990;525:321-30.